Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
L Rong, J Zou, W Ran, X Qi, Y Chen, H Cui… - Frontiers in …, 2023 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a series of diseases, involving excessive lipid
deposition in the liver and is often accompanied by obesity, diabetes, dyslipidemia …
deposition in the liver and is often accompanied by obesity, diabetes, dyslipidemia …
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review
Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different
entities sharing common clinical and physio-pathological features, with insulin resistance …
entities sharing common clinical and physio-pathological features, with insulin resistance …
Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …
Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …
Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): a narrative review
Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide
with a complex etiology attributed to behavioural, environmental, and genetic causes. The …
with a complex etiology attributed to behavioural, environmental, and genetic causes. The …
Perspectives on precision medicine approaches to NAFLD diagnosis and management
Precision medicine defines the attempt to identify the most effective approaches for specific
subsets of patients based on their genetic background, clinical features, and environmental …
subsets of patients based on their genetic background, clinical features, and environmental …
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact
Non-Alcoholic Fatty Liver Disease (NAFLD) is caused by the accumulation of fat in over 5%
of hepatocytes in the absence of alcohol consumption. NAFLD is considered the hepatic …
of hepatocytes in the absence of alcohol consumption. NAFLD is considered the hepatic …
Liver fat as risk factor of hepatic and cardiometabolic diseases
Non‐alcoholic fatty liver disease (NAFLD) is a disorder characterized by excessive
accumulation of fat in the liver that can progress to liver inflammation (non‐alcoholic …
accumulation of fat in the liver that can progress to liver inflammation (non‐alcoholic …
Diet and exercise in NAFLD/NASH: beyond the obvious
Lifestyle represents the most relevant factor for non‐alcoholic fatty liver disease (NAFLD) as
the hepatic manifestation of the metabolic syndrome. Although a tremendous body of clinical …
the hepatic manifestation of the metabolic syndrome. Although a tremendous body of clinical …
Is there an 'ideal'diet for patients with NAFLD?
Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic that encompasses three
distinct clinical phenotypes: uncomplicated fatty liver, nonalcoholic steatohepatitis (NASH) …
distinct clinical phenotypes: uncomplicated fatty liver, nonalcoholic steatohepatitis (NASH) …